Bristol-Myers Squibb faces a soft growth outlook, but high expected free cash flow and steady sales suggest today's valuation is simply too low. With a dividend yield now near 6%, I outline key ...
Myrtle T. (Taylor) Myers, 83, of Bristol, widow of George Myers, died Thursday (February 20, 2003) at Sheriden Woods Health Care Center. Mrs. Myers was born in Bristol on April 18, 1919 and was a ...
JOHNSON, Shirley A. Shirley A. Johnson, 72, died Wednesday, (October 25, 2006) at the Connecticut Hospice in Branford after a long illness. Born in Bristol, where she spent most of her life ...
Breyanzi recently received accelerated approval from the FDA for adult patients with relapsed or refractory FL, who have received two or more prior lines of systemic therapy. The FDA also granted ...
The study was sponsored by the Netherlands Cancer Institute and the Melanoma Institute Australia and funded by Bristol Myers Squibb and the National Health and Medical Research Council Australia.
(RTTNews) - Bristol-Myers Squibb Co. (BMY), Monday announced that data from its three studies and a three-year follow-up from the Phase 3 TRANSFORM trial of Breyanzi showed consistent clinical ...
Bristol Myers Squibb (NYSE:BMY) announced Saturday that its FDA-authorized cancer therapy Krazati (adagrasib), acquired with its $4.8B Mirati (MRTX) buyout this year, reached its main goal in a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol Myers Squibb BMY announced data from three studies evaluating CD19-directed CAR T cell therapy Breyanzi (liso-cel) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition. Karuna’s crown jewel, an ...